Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
April 16, 2025
What’s new in breast cancer research? SABCS24 looks at ctDNA, AI and ‘right-sizing’ treatment
Large research symposium highlights liquid biopsies, new drug combos, shifts in surgical practice and, yes, patient voices
Obliteride brings in $2M to spur cancer, COVID-19 research
Annual Fred Hutch fundraiser goes virtual and DIY; sets records for participation, creativity and global reach
Riding out the pandemic with Obliteride
Annual fundraiser goes DIY with creative workouts, global participation and Glow Orange week
The latest on how COVID-19 affects cancer patients
Hutch researchers share new data on mortality rates and racial disparities in treatment; launch statewide COVID-19 and cancer data repository
Trio of studies to evaluate metastatic breast cancer care
Hutch researcher awarded grants to study the use of biopsy to drive therapy choices and test new type of PET scan to stage lobular
Preventing brain metastasis in breast cancer
New $2.4M NCI grant funds research aimed at preventing disseminated tumor cells in the brain from waking up
Improving apps to help cancer patients quit smoking
Fred Hutch cancer prevention researcher awarded $3.5M NCI grant to run randomized trial of smartphone health apps
Eating ‘the rainbow’ and other food tips for uncertain times
COVID-19 and cancer call for comfort food, but experts say baking with ‘whole-food ingredients’ and eating mostly plants will better support your immune system
COVID-19 and cancer expose society’s health care gaps
Fred Hutch researchers work to disrupt health disparities and misinformation as coronavirus ravages the medically underserved
What happens when cancer patients get COVID-19?
Large new observational study of nearly 1,000 patients breaks down who’s most at risk with coronavirus, highlights need for additional care
Immune response in colorectal cancer: What helps, what hurts?
GECCO collaboration drills into mechanisms of specific T-cell response to germline variations, lifetime exposures and tumor environment
NIH grant to fund new financial-toxicity intervention
Randomized trial will test benefit of proactive financial counseling and navigation for cancer patients and caregivers